Noninvasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging.
Read More
Under a new agreement, Biodesix and Inivata will investigate the clinical utility of blood-based next-generation sequencing tests for patients with non-small cell lung cancer.
Read More
In a recent study, the ISET test by Rarecells detected lung cancer in patients with no symptoms, allowing for surgical removal prior to metastasis.
Read MoreVela Diagnostics, Singapore, has announced the availability of the Sentosa SQ Non-Small Cell Lung Cancer panel and the Sentosa Colorectal Cancer panel for next-generation sequencing-based detection of sequence variants, for research use only by early-access customers.
Read More
A blood test for the early detection of lung cancer will soon be offered through standard clinical channels as well as directly to consumers.
Read More